Skip to main content
. 2018 Aug 31;9(68):33043–33049. doi: 10.18632/oncotarget.25984

Figure 2. Computed tomography (CT) findings.

Figure 2

Three target lesions (red arrows) were identified in basal CT scan corresponding to lung metastasis (A), mediastinal lymph adenopathy (B), and liver metastasis (C). All these lesions showed a partial response after 4 cycles of nivolumab, which was maintained until the last CT scan (42 weeks). Progression of the axillary right lymph node that appeared as a new lesion at week 28 (D). Flare disease progression in the liver with the apparition of new uncountable liver metastasis in the last CT scan causing hepatic failure (E).